canceldeath

Protein restriction

Behavioral · Evidence and recent research

Notify me when meaningful evidence changes.

Where things stand

Reducing protein is not a simple healthy-ageing rule. Protein is needed to maintain muscle, and older adults can respond less strongly to a given amount of dietary protein. Research on nutrient signalling must therefore be balanced against physical function and muscle loss; a proposed ageing mechanism does not establish that eating less protein benefits an older person. Source ↗ Recently: No update dated within the past 30 days is recorded in our collection. This describes our coverage, not a conclusion that the wider research is unchanged.

AI-written overview · not expert-reviewed · Background sources checked Sep 23, 2026 · Recent updates cover the last 30 days of this collection. A new report does not automatically change the evidence assessment.

Review: protein and muscle in older adults ↗

Regulatory status
Not applicable
Availability
Widely available
Category
Behavioral
Human results verified here
0

Evidence collection is needs review. 0 approved assessments; 16 assessments awaiting review; 0 published studies with verified results. Safety: not assessed.

Methodology →

A numeric breakdown will be available after baseline review. Safety is not yet assessed.

Evidence events affecting this intervention

Browse all evidence →
Registry update — unassessed

Effect of a Pulse-based USDA-diet on Gut Microbial Metabolites and Biomarkers of Healthspan: A 18-week Randomized Controlled Crossover Feeding Study in Older Adults

Trial registry update: COMPLETED. No results reported in the supplied registry record.

RCT1mo
Registry update — unassessed

Randomized Controlled Trial of Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome

Trial registry update: COMPLETED. No results reported in the supplied registry record.

RCT1mo
Assessment superseded

RCT of metformin and lifestyle intervention in metabolic syndrome, results not reported

This was a Phase III randomized controlled trial in people with metabolic syndrome designed to test whether metformin and comprehensive lifestyle changes (moderate physical activity, Mediterranean/macrobiotic diet with calorie and protein restriction) prevent age-related chronic diseases. The abstract describes only the study design and aims; no results or outcomes are reported.

RCT1mo

The 25 most recent recorded changes, including corrections and backfill

Historical record correctionSource updated; previous assessment withdrawn

No published human results verified in this collection yet

No preclinical studies tracked yet

Randomized Controlled Trial of Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome
Effect of a Pulse-based USDA-diet on Gut Microbial Metabolites and Biomarkers of Healthspan: A 18-week Randomized Controlled Crossover Feeding Study in Older Adults